These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7829637)

  • 21. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans.
    Park YJ; Chung HK; Park DJ; Kim WB; Kim SW; Koh JJ; Cho BY
    Thyroid; 2000 Jun; 10(6):453-9. PubMed ID: 10907987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologically-related or incidental coexistence of diabetes mellitus and Graves' disease; discrimination by anti-GAD antibody measurement.
    Kusaka I; Nagasaka S; Fujibayashi K; Hayashi H; Kawakami A; Nakamura T; Rokkaku K; Saito T; Higashiyama M; Honda K; Ishikawa S; Saito T
    Endocr J; 1999 Dec; 46(6):747-54. PubMed ID: 10724349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CTLA-4 AT-repeat polymorphism reduces the inhibitory function of CTLA-4 in Graves' disease.
    Takara M; Kouki T; DeGroot LJ
    Thyroid; 2003 Dec; 13(12):1083-9. PubMed ID: 14751028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
    Yin X; Latif R; Bahn R; Tomer Y; Davies TF
    Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.
    Donner H; Rau H; Walfish PG; Braun J; Siegmund T; Finke R; Herwig J; Usadel KH; Badenhoop K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):143-6. PubMed ID: 8989248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CT60 single nucleotide polymorphism of the CTLA-4 gene is associated with susceptibility to Graves' disease in the Taiwanese population.
    Weng YC; Wu MJ; Lin WS
    Ann Clin Lab Sci; 2005; 35(3):259-64. PubMed ID: 16081581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The genetics of Graves' disease.
    Gough SC
    Endocrinol Metab Clin North Am; 2000 Jun; 29(2):255-66. PubMed ID: 10874528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTLA-4 promoter variants in patients with Graves' disease and Hashimoto's thyroiditis.
    Braun J; Donner H; Siegmund T; Walfish PG; Usadel KH; Badenhoop K
    Tissue Antigens; 1998 May; 51(5):563-6. PubMed ID: 9672157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CTLA-4 and HLA gene susceptibility to thyroid-associated orbitopathy.
    Buzzetti R; Nisticò L; Signore A; Cascino I
    Lancet; 1999 Nov; 354(9192):1824. PubMed ID: 10577673
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population.
    Awata T; Kurihara S; Iitaka M; Takei S; Inoue I; Ishii C; Negishi K; Izumida T; Yoshida Y; Hagura R; Kuzuya N; Kanazawa Y; Katayama S
    Diabetes; 1998 Jan; 47(1):128-9. PubMed ID: 9421386
    [No Abstract]   [Full Text] [Related]  

  • 31. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production.
    Tomer Y; Greenberg DA; Barbesino G; Concepcion E; Davies TF
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1687-93. PubMed ID: 11297604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTLA-4 gene polymorphism and its association with Graves' disease in the Lebanese population.
    Nakkash-Chmaisse H; Makki RF; Abdelhamid E; Fakhoury H; Salti NN; Salti I
    Eur J Immunogenet; 2004 Jun; 31(3):141-3. PubMed ID: 15182328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease.
    Allahabadia A; Heward JM; Nithiyananthan R; Gibson SM; Reuser TT; Dodson PM; Franklyn JA; Gough SC
    Lancet; 2001 Sep; 358(9286):984-5. PubMed ID: 11583755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus.
    Heward J; Gordon C; Allahabadia A; Barnett AH; Franklyn JA; Gough SC
    Ann Rheum Dis; 1999 Mar; 58(3):193-5. PubMed ID: 10364920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of an independent association between the human leukocyte antigen allele DQA1*0501 and Graves' disease.
    Cuddihy RM; Bahn RS
    J Clin Endocrinol Metab; 1996 Feb; 81(2):847-9. PubMed ID: 8636314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for a Graves' disease susceptibility locus at chromosome Xp11 in a United Kingdom population.
    Imrie H; Vaidya B; Perros P; Kelly WF; Toft AD; Young ET; Kendall-Taylor P; Pearce SH
    J Clin Endocrinol Metab; 2001 Feb; 86(2):626-30. PubMed ID: 11158020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
    Agarwal K; Czaja AJ; Jones DE; Donaldson PT
    Hepatology; 2000 Jan; 31(1):49-53. PubMed ID: 10613727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The aetiology of Graves' disease: what is the genetic contribution?
    Philippou G; McGregor AM
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):393-5. PubMed ID: 9640403
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1*07.
    Kula D; Bednarczuk T; Jurecka-Lubieniecka B; Polanska J; Hasse-Lazar K; Jarzab M; Steinhof-Radwanska K; Hejduk B; Zebracka J; Kurylowicz A; Bar-Andziak E; Stechly T; Pawlaczek A; Gubala E; Krawczyk A; Szpak-Ulczok S; Nauman J; Jarzab B
    Thyroid; 2006 May; 16(5):447-53. PubMed ID: 16756466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong association between HLA-DQA1*0501 and Graves' disease in a male Caucasian population.
    Yanagawa T; Mangklabruks A; DeGroot LJ
    J Clin Endocrinol Metab; 1994 Jul; 79(1):227-9. PubMed ID: 8027232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.